Similar results were obtained when silencing the P2X7 receptor in both leukemic cell lines and leukemia-initiating stem cells (Feng et al., 2020; He et al., 2020), thus reproducing the effect of P2X7 ablation in solid cancer models (Adinolfi et al., 2012b). The gene discussed is P2RX7; the disease is leukemia.